Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations

NCT05103605 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

274

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Osimertinib

Sponsor

AstraZeneca